<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>5(1)</volume><submitter>Segawa T</submitter><pubmed_abstract>&lt;h4>Aims&lt;/h4>This study aimed to investigate the relationship between corticosteroid therapy and long-term outcomes in patients with cardiac sarcoidosis, stratified by left ventricular ejection fraction (LVEF) at diagnosis.&lt;h4>Methods and results&lt;/h4>This study conducted a &lt;i>post hoc&lt;/i> analysis of the ILLUstration of the Management and prognosIs of JapaNese PATiEnts with Cardiac Sarcoidosis, a retrospective multicentre registry. Cardiac sarcoidosis was diagnosed based on the 2016 Japanese Circulation Society and 2014 Heart Rhythm Society criteria. The primary endpoint was a composite of all-cause death, hospitalization for heart failure, and fatal ventricular arrhythmia events. Patients were divided into three groups based on LVEF: preserved LVEF (≥50%, &lt;i>n&lt;/i> = 251), moderately impai</pubmed_abstract><journal>European heart journal open</journal><pagination>oeae100</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11720171</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Corticosteroid therapy and long-term outcomes in patients with cardiac sarcoidosis stratified by left ventricular ejection fraction.</pubmed_title><pmcid>PMC11720171</pmcid><pubmed_authors>Segawa T</pubmed_authors><pubmed_authors>Kitai T</pubmed_authors><pubmed_authors>Tanaka H</pubmed_authors><pubmed_authors>Baba Y</pubmed_authors><pubmed_authors>Naruse Y</pubmed_authors><pubmed_authors>Matsue Y</pubmed_authors><pubmed_authors>Sakata Y</pubmed_authors><pubmed_authors>Taniguchi T</pubmed_authors><pubmed_authors>Yoshioka K</pubmed_authors><pubmed_authors>Nabeta T</pubmed_authors><pubmed_authors>Okumura T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Corticosteroid therapy and long-term outcomes in patients with cardiac sarcoidosis stratified by left ventricular ejection fraction.</name><description>&lt;h4>Aims&lt;/h4>This study aimed to investigate the relationship between corticosteroid therapy and long-term outcomes in patients with cardiac sarcoidosis, stratified by left ventricular ejection fraction (LVEF) at diagnosis.&lt;h4>Methods and results&lt;/h4>This study conducted a &lt;i>post hoc&lt;/i> analysis of the ILLUstration of the Management and prognosIs of JapaNese PATiEnts with Cardiac Sarcoidosis, a retrospective multicentre registry. Cardiac sarcoidosis was diagnosed based on the 2016 Japanese Circulation Society and 2014 Heart Rhythm Society criteria. The primary endpoint was a composite of all-cause death, hospitalization for heart failure, and fatal ventricular arrhythmia events. Patients were divided into three groups based on LVEF: preserved LVEF (≥50%, &lt;i>n&lt;/i> = 251), moderately impai</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2025-04-04T03:06:01.382Z</modification><creation>2025-04-04T03:06:01.382Z</creation></dates><accession>S-EPMC11720171</accession><cross_references><pubmed>39801602</pubmed><doi>10.1093/ehjopen/oeae100</doi></cross_references></HashMap>